RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      Effect of Valproic acid, a Histone Deacetylase Inhibitor, on the Expression of Pluripotency and Neural Crest Specific Marker Genes in Murine Multipotent Skin Precursor Cells

      한글로보기

      https://www.riss.kr/link?id=A82447760

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Cells that have endogenous multipotent properties can be used as a starting source for the generation of induced pluripotent cells (iPSC). In addition, small molecules associated with epigenetic reprogramming are also widely used to enhance the multi-...

      Cells that have endogenous multipotent properties can be used as a starting source for the generation of induced pluripotent cells (iPSC). In addition, small molecules associated with epigenetic reprogramming are also widely used to enhance the multi- or pluripotency of such cells. Skinderived precursor cells (SKPs) are multipotent, sphereforming and embryonic neural crest-related precursor cells. These cells can be isolated from a juvenile or adult mammalian dermis. SKPs are also an efficient starting cell source for reprogramming and the generation of iPSCs because of the high expression levels of Sox2 and Klf4 in these cells as well as their endogenous multipotency. In this study, valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, was tested in the generation of iPSCs as a potential enhancer of the reprogramming potential of SKPs. SKPs were isolated from the back skins of 5-6 week old C57BL/6 X DBA/2 F1 mice. After passage 3, the SKPs was treated with 2 mM of VPA and the quantitative real time RT-PCR was performed to quantify the expression of Oct4 and Klf4 (pluripotency specific genes), and Snai2 and Ngfr (neural crest specific genes). The results show that Oct4 and Klf4 expression was decreased by VPA treatment. However, there were no significant changes in neural crest specific gene expression following VPA treatment. Hence, although VPA is one of the most potent of the HDAC inhibitors, it does not enhance the reprogramming of multipotent skin precursor cells in mice.

      더보기

      참고문헌 (Reference)

      1 Wernig M, "c-Myc is dispensable for direct reprogramming of mouse fibroblasts" 2 : 10-12, 2008

      2 Bug G, "Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells" 65 : 2537-2541, 2005

      3 Yu IT, "Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation" 56 : 473-480, 2009

      4 Jung GA, "Valproic acid induces differentiation and inhibition of proliferation in neural progenitor cells via the beta-catenin-Ras-ERK-p21Cip/WAF1 pathway" 9 : 66-, 2008

      5 Teng HF, "Valproic acid enhances Oct4 promoter activity in myogenic cells" 110 : 995-1004, 2010

      6 Kuendgen A, "The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia" 106 : 112-119, 2006

      7 Biernaskie J, "Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury" 27 : 9545-9559, 2007

      8 McKenzie IA, "Skin derived precursors generate myelinating Schwann cells for the injured and dysmyelinated nervous system" 26 : 6651-6660, 2006

      9 Qiu Z, "Skeletal myogenic potential of mouse skin-derived precursors" 19 : 259-268, 2010

      10 Niwa H, "Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells" 24 : 372-376, 2000

      1 Wernig M, "c-Myc is dispensable for direct reprogramming of mouse fibroblasts" 2 : 10-12, 2008

      2 Bug G, "Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells" 65 : 2537-2541, 2005

      3 Yu IT, "Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation" 56 : 473-480, 2009

      4 Jung GA, "Valproic acid induces differentiation and inhibition of proliferation in neural progenitor cells via the beta-catenin-Ras-ERK-p21Cip/WAF1 pathway" 9 : 66-, 2008

      5 Teng HF, "Valproic acid enhances Oct4 promoter activity in myogenic cells" 110 : 995-1004, 2010

      6 Kuendgen A, "The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia" 106 : 112-119, 2006

      7 Biernaskie J, "Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury" 27 : 9545-9559, 2007

      8 McKenzie IA, "Skin derived precursors generate myelinating Schwann cells for the injured and dysmyelinated nervous system" 26 : 6651-6660, 2006

      9 Qiu Z, "Skeletal myogenic potential of mouse skin-derived precursors" 19 : 259-268, 2010

      10 Niwa H, "Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells" 24 : 372-376, 2000

      11 Kim JB, "Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors" 454 : 646-650, 2008

      12 Perucca E, "Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience" 16 : 695-714, 2002

      13 Li Y, "Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4" 105 : 635-637, 2005

      14 Hunt DP, "Multipotent skin-derived precursors: from biology to clinical translation" 20 : 522-530, 2009

      15 Fernandes KJ, "Multipotent skin-derived precursors: adult neural crest-related precursors with therapeutic potential" 363 : 185-198, 2008

      16 Zhang P, "Kruppel-like factor 4 (Klf4) prevents embryonic stem (ES) cell differentiation by regulating Nanog gene expression" 285 : 9180-9189, 2010

      17 Fernandes KJ, "Isolation, expansion, and differentiation of mouse skin-derived precursors" 482 : 159-170, 2009

      18 Toma JG, "Isolation of multipotent adult stem cells from the dermis of mammalian skin" 3 : 778-784, 2001

      19 Toma JG, "Isolation and characterization of multipotent skin-derived precursors from human skin" 23 : 727-737, 2005

      20 Takahashi K, "Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors" 126 : 663-676, 2006

      21 Takahashi K, "Induction of pluripotent stem cells from adult human fibroblasts by defined factors" 131 : 861-872, 2007

      22 Huangfu D, "Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds" 26 : 795-797, 2008

      23 Yu J, "Induced pluripotent stem cell lines derived from human somatic cells" 318 : 1917-1920, 2007

      24 Buranasinsup S, "In vitro osteogenesis from human skin-derived precursor cells" 48 : 263-269, 2006

      25 Phiel CJ, "Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen" 276 : 36734-36741, 2001

      26 Hsieh J, "Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells" 101 : 16659-16664, 2004

      27 Nakagawa M, "Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts" 26 : 101-106, 2008

      28 Loh YH, "Generation of induced pluripotent stem cells from human blood" 113 : 5476-5479, 2009

      29 Okita K, "Generation of germline-competent induced pluripotent stem cells" 448 : 313-317, 2007

      30 Nichols J, "Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4" 95 : 379-391, 1998

      31 Sun N, "Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells" 106 : 15720-15725, 2009

      32 Hanna J, "Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency" 133 : 250-264, 2008

      33 Kim JB, "Direct reprogramming of human neural stem cells by OCT4" 461 : 643-649, 2009

      34 Eminli S, "Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells" 41 : 968-976, 2009

      35 Schuh R, "A conserved family of nuclear proteins containing structural elements of the finger protein encoded by Kruppel, a Drosophila segmentation gene" 47 : 1025-1032, 1986

      36 Shi Y, "A combined chemical and genetic approach for the generation of induced pluripotent stem cells" 2 : 525-528, 2008

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2022 평가예정 계속평가 신청대상 (계속평가)
      2021-12-01 평가 등재후보로 하락 (재인증) KCI등재후보
      2018-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2015-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2007-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2005-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.15 0.15 0.14
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.11 0.09 0.282 0.03
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼